RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis : molecular analysis of the PAC203 cohort
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Leukemia - 37(2023), 12 vom: 20. Dez., Seite 2497-2501 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
O'Sullivan, J M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
82S8X8XX8H |
|---|
| Anmerkungen: |
Date Completed 29.11.2023 Date Revised 13.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41375-023-02027-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363564551 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363564551 | ||
| 003 | DE-627 | ||
| 005 | 20240313233722.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-023-02027-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1326.xml |
| 035 | |a (DE-627)NLM363564551 | ||
| 035 | |a (NLM)37864122 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a O'Sullivan, J M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis |b molecular analysis of the PAC203 cohort |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.11.2023 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a ruxolitinib |2 NLM | |
| 650 | 7 | |a 82S8X8XX8H |2 NLM | |
| 650 | 7 | |a Nitriles |2 NLM | |
| 650 | 7 | |a Pyrimidines |2 NLM | |
| 700 | 1 | |a Taylor, J |e verfasserin |4 aut | |
| 700 | 1 | |a Gerds, A |e verfasserin |4 aut | |
| 700 | 1 | |a Buckley, S |e verfasserin |4 aut | |
| 700 | 1 | |a Harrison, C N |e verfasserin |4 aut | |
| 700 | 1 | |a Oh, S |e verfasserin |4 aut | |
| 700 | 1 | |a List, A F |e verfasserin |4 aut | |
| 700 | 1 | |a Howard, K |e verfasserin |4 aut | |
| 700 | 1 | |a Dreau, H |e verfasserin |4 aut | |
| 700 | 1 | |a Hamblin, A |e verfasserin |4 aut | |
| 700 | 1 | |a Mead, A J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d 1989 |g 37(2023), 12 vom: 20. Dez., Seite 2497-2501 |w (DE-627)NLM012593788 |x 1476-5551 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2023 |g number:12 |g day:20 |g month:12 |g pages:2497-2501 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41375-023-02027-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2023 |e 12 |b 20 |c 12 |h 2497-2501 | ||